Literature DB >> 25270911

Unfolding properties of recombinant human serum albumin products are due to bioprocessing steps.

Brian E Lang1, Kenneth D Cole.   

Abstract

We have used differential scanning calorimetry (DSC) to determine the unfolding properties of commercial products of human serum albumin (HSA) prepared from pooled human blood, transgenic yeast, and transgenic rice. The initial melting temperatures (Tm1 ) for the unfolding transitions of the HSA products varied from 62°C to 75°C. We characterized the samples for purity, fatty acid content, and molecular weight. The effects of adding fatty acids, heat pasteurization, and a low pH defatting technique on the transition temperatures were measured. Defatted HSA has a structure with the lowest stability (Tm of ∼62°C). When fatty acids are bound to HSA, the structure is stabilized (Tm of ∼64-72°C), and prolonged heating (pasteurization at 60°C) results in a heat-stabilized structural form containing fatty acids (Tm of ∼75-80°C). This process was shown to be reversible by a low pH defatting step. This study shows that the fatty acid composition and bioprocessing history of the HSA commercial products results in the large differences in the thermal stability.
© 2014 American Institute of Chemical Engineers.

Entities:  

Keywords:  and thermodynamics; biopharmaceutical; differential scanning calorimetry (DSC); human serum albumin; recombinant proteins; thermal unfolding

Mesh:

Substances:

Year:  2014        PMID: 25270911     DOI: 10.1002/btpr.1996

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  2 in total

1.  Conformational stability as a quality attribute for the cell therapy raw material human serum albumin.

Authors:  Evelien Wynendaele; Gamaliel Junren Ma; Xiaolong Xu; Nam-Joon Cho; Bart De Spiegeleer
Journal:  RSC Adv       Date:  2021-04-23       Impact factor: 3.361

2.  AlbuCORE: an albumin-based molecular scaffold for multivalent biologics design.

Authors:  Mario Sanches; Igor D'Angelo; Maria Jaramillo; Jason Baardsnes; John Zwaagstra; Joe Schrag; Ian Schoenhofen; Mauro Acchione; Sam Lawn; Grant Wickman; Nina Weisser; David K Y Poon; Gordon Ng; Surjit Dixit
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.